Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Wellbeing Digital Sciences Inc
(OP:
KONEF
)
N/A
UNCHANGED
Last Price
Updated: 3:57 PM EST, Mar 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Wellbeing Digital Sciences Inc
< Previous
1
2
Next >
Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
June 19, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group
June 16, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference
May 25, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response
May 03, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
April 18, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
April 11, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Announces Cease Trade Order
April 06, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Provides Bi-Weekly Default Status Report
March 16, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital to Participate at the Benzinga Psychedelic Capital Conference
March 16, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion
March 13, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital to Participate in The Global Biomedical Design Conference
March 09, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Applies for a Controlled Substances Dealers License and Receives Approval to Proceed with Buildout
March 08, 2023
From
WELLBEING DIGITAL SCIENCES
Via
Business Wire
Wellbeing Provides Bi-Weekly Default Status Report
March 02, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital to Participate in MarigoldLIVE: International Women’s Day Networking Event
March 01, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Provides Bi-Weekly Default Status Report
February 16, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity.
February 15, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial
February 14, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Announces Delay in Filing Its Financial Statements and Management Cease Trade Order
February 01, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar
January 25, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital Announces Change of Auditor
January 18, 2023
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial
December 22, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada
December 08, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response
December 06, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
November 30, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary Mindscape Treats its 1,000th Patient
November 29, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital Announces the Appointment of Mohammad Sharifi to Board of Directors
November 22, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital Announces Resignation of Directors
November 18, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial
November 17, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers
November 14, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
Wellbeing Digital Subsidiary KGK to Participate in Microdose Wonderland Miami Conference
November 02, 2022
From
Wellbeing Digital Sciences Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.